Celanese/$CE
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Celanese
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
- Ticker
- $CE
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 11,434
- Headquarters
- Irving, United States
- Website
- www.celanese.com
Celanese Metrics
BasicAdvanced
$4.8B
-
-$10.64
0.75
$0.12
0.27%
Price and volume
Market cap
$4.8B
Beta
0.75
52-week high
$70.70
52-week low
$35.13
Average daily volume
1.8M
Dividend rate
$0.12
Financial strength
Current ratio
1.447
Quick ratio
0.807
Long term debt to equity
2.4
Total debt to equity
2.702
Interest coverage (TTM)
1.22%
Profitability
EBITDA (TTM)
1,677
Gross margin (TTM)
21.38%
Net profit margin (TTM)
-12.04%
Operating margin (TTM)
9.53%
Effective tax rate (TTM)
-1.96%
Revenue per employee (TTM)
$850,000
Management effectiveness
Return on assets (TTM)
2.44%
Return on equity (TTM)
-22.25%
Valuation
Price to revenue (TTM)
0.499
Price to book
1.16
Price to tangible book (TTM)
-1.59
Price to free cash flow (TTM)
6.844
Free cash flow yield (TTM)
14.61%
Free cash flow per share (TTM)
6.457
Dividend yield (TTM)
0.27%
Forward dividend yield
0.27%
Growth
Revenue change (TTM)
-2.17%
Earnings per share change (TTM)
-29.12%
3-year revenue growth (CAGR)
-1.93%
10-year revenue growth (CAGR)
5.85%
3-year earnings per share growth (CAGR)
-2.79%
10-year earnings per share growth (CAGR)
16.53%
3-year dividend per share growth (CAGR)
-64.92%
10-year dividend per share growth (CAGR)
-20.95%
What the Analysts think about Celanese
Analyst ratings (Buy, Hold, Sell) for Celanese stock.
Analyst projections of the future price of Celanese stock.
Bulls say / Bears say
Celanese delivered a strong second quarter: adjusted EPS was $2.45, while sales rose 18% sequentially on higher volume and pricing. Medical and electronics also provided momentum in Engineered Materials, giving the recovery some higher-value growth drivers. (Celanese SEC filing, Celanese)
The company is cutting structural costs rather than waiting for the chemicals cycle to improve. Its Ulsan closure, nylon 6,6 network optimisation and Lanaken shutdown are expected to deliver more than $50 million of annualised fixed-cost savings, with a further $80 million to $100 million of reductions targeted for 2027. (Celanese SEC filing, The Motley Fool)
Deleveraging could become a self-reinforcing catalyst if cash flow holds. Management still expects $700 million to $800 million of 2026 free cash flow, while the $152 million Nutrinova stake sale will be used for debt maturities and supports targets of roughly $10 billion net debt by year-end 2026 and $9 billion by 2027. (FinancialContent, The Motley Fool)
The second-quarter surge is not a clean run-rate. Celanese expects third-quarter adjusted EPS of only $1.35 to $1.75 as supply-related benefits moderate, raw-material costs rise and accelerated closures create inventory absorption charges. (Celanese SEC filing, GoodMoat)
The balance sheet remains the central risk. At the end of June, Celanese had about $12.0 billion of long-term debt against $1.36 billion of cash, leaving roughly $10.6 billion of net debt and limited room if operating cash flow or refinancing conditions deteriorate. (Celanese SEC filing, Celanese SEC filing)
Higher sales are not yet translating into stronger reported profits. Second-quarter GAAP net income fell to $125 million from $197 million a year earlier, while automotive volumes weakened and acetate-tow destocking continued, pointing to fragile demand and margin conversion. (Simply Wall St, Celanese SEC filing)
Data summarised monthly by Lightyear AI. Last updated on 22 Sept 2026.
Celanese Financial Performance
Revenues and expenses
Celanese Earnings Performance
Company profitability
Upcoming events
No upcoming events
Celanese News
AllArticlesVideos
Funds containing Celanese
AllUSDGBPEUR
Fund name | Fund size | $CE weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.26% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.26% |
iShares MSCI World Small Cap$WSML | $9B | 0.05% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.05% |
iShares MSCI World Small Cap£WLDS | £6.7B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.